Atlas Trials

An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT01835093 · COMPLETED

Trial details

NCT number
NCT01835093
Sponsor
Chiba University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Attention Deficit Disorder With Hyperactivity
Start date
2013-04-01
Primary completion
2013-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.